v3.26.1
Consolidated Statement of Convertible Preferred Stock and Stockholders' Deficit - USD ($)
Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Total
Balance at Dec. 31, 2024   $ 36,000 $ 617,530,000 $ (649,154,000) $ (42,000) $ (31,630,000)
Balance (in shares) at Dec. 31, 2024 7,398 3,650,731        
Increase (Decrease) in Stockholders' Equity (Deficit)            
Stock-based compensation     266,000     266,000
Transaction costs paid through the issuance of stock (in shares)   6,509        
Shares issued for vested restricted stock units   $ 16,000 3,141,000     3,157,000
Shares issued for vested restricted stock units (in shares)   1,565,047        
Reclassification of warrant liability upon exercise of prefunded warrants and amended warrant agreements     15,827,000     15,827,000
Exercise of prefunded warrants   $ 16,000       16,000
Exercise of prefunded warrants (in shares)   1,582,559        
Conversion of Series C Preferred shares into common stock   $ 3,000 (3,000)      
Conversion of Series C Preferred shares into common stock (in shares) (661) 264,302        
Other comprehensive loss         51,000 51,000
Net (loss) income       20,575,000   20,575,000
Balance at Jun. 30, 2025   $ 71,000 636,761,000 (628,579,000) 9,000 8,262,000
Balance (in shares) at Jun. 30, 2025 6,737 7,069,148        
Balance at Mar. 31, 2025   $ 50,000 633,633,000 (627,664,000) (19,000) 6,000,000
Balance (in shares) at Mar. 31, 2025 7,398 5,076,598        
Increase (Decrease) in Stockholders' Equity (Deficit)            
Stock-based compensation     105,000     105,000
Shares issued for vested restricted stock units (in shares)   5,301        
Issuance of common stock and warrants, net of offering costs   $ 16,000 3,026,000     3,042,000
Issuance of common stock and warrants, net of offering costs (in shares)   1,522,947        
Exercise of prefunded warrants   $ 2,000       2,000
Exercise of prefunded warrants (in shares)   200,000        
Conversion of Series C Preferred shares into common stock   $ 3,000 (3,000)      
Conversion of Series C Preferred shares into common stock (in shares) (661) 264,302        
Other comprehensive loss         28,000 28,000
Net (loss) income       (915,000)   (915,000)
Balance at Jun. 30, 2025   $ 71,000 636,761,000 (628,579,000) 9,000 8,262,000
Balance (in shares) at Jun. 30, 2025 6,737 7,069,148        
Balance at Dec. 31, 2025   $ 90,000 639,259,000 (639,984,000) 6,000 (629,000)
Balance (in shares) at Dec. 31, 2025 6,737 9,067,774        
Increase (Decrease) in Stockholders' Equity (Deficit)            
Stock-based compensation     1,450,000     1,450,000
Shares issued for vested restricted stock units (in shares)   10,113        
Issuance of common stock and warrants, net of offering costs   $ 62,000 10,980,000     11,042,000
Issuance of common stock and warrants, net of offering costs (in shares)   6,186,925        
Other comprehensive loss         (11,000) (11,000)
Net (loss) income       (10,161,000)   (10,161,000)
Balance at Jun. 30, 2026   $ 152,000 651,689,000 (650,145,000) (5,000) 1,691,000
Balance (in shares) at Jun. 30, 2026 6,737 15,264,812        
Balance at Mar. 31, 2026   $ 101,000 641,681,000 (647,091,000) (2,000) (5,311,000)
Balance (in shares) at Mar. 31, 2026 6,737 10,162,587        
Increase (Decrease) in Stockholders' Equity (Deficit)            
Stock-based compensation     816,000     816,000
Shares issued for vested restricted stock units (in shares)   5,300        
Issuance of common stock and warrants, net of offering costs   $ 51,000 9,192,000     9,243,000
Issuance of common stock and warrants, net of offering costs (in shares)   5,096,925        
Other comprehensive loss         (3,000) (3,000)
Net (loss) income       (3,054,000)   (3,054,000)
Balance at Jun. 30, 2026   $ 152,000 $ 651,689,000 $ (650,145,000) $ (5,000) $ 1,691,000
Balance (in shares) at Jun. 30, 2026 6,737 15,264,812